LEFÉMI 2,5 MG COM REV CT BL AL PLAS PVC/PVDC OPC X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1023512820011 -
GGREM
541819010100404 -
Código de barras
7896004762395
O que a fonte publica
- Detentor do registro
- EMS S/A
- Princípios ativos
- LETROZOL
- Embalagem
- 2,5 MG COM REV CT BL AL PLAS PVC/PVDC OPC X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- L2B3 - CITOSTÁTICOS INIBIDORES DA AROMATASE
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "LEFÉMI 2,5 MG COM REV CT BL AL PLAS PVC/PVDC OPC X 30",
"holder": "EMS S/A",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896004762395"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "541819010100404",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": true,
"holderTaxId": "57.507.378/0003-65",
"priceRegime": "Regulado",
"productName": "LEFÉMI",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "2,5 MG COM REV CT BL AL PLAS PVC/PVDC OPC X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "806.31",
"icms-12": "916.26",
"icms-17": "971.46",
"icms-18": "983.30",
"icms-19": "995.44",
"icms-20": "1007.89",
"icms-21": "1020.65",
"icms-22": "1033.73",
"icms-23": "1047.16",
"icms-17.5": "977.35",
"icms-19.5": "1001.63",
"icms-20.5": "1014.23",
"icms-22.5": "1040.40",
"icms-12-alc": "905.27",
"icms-17-alc": "959.80",
"icms-18-alc": "971.51",
"icms-19-alc": "983.50",
"icms-20-alc": "995.79",
"icms-21-alc": "1008.40",
"icms-22-alc": "1021.33",
"icms-23-alc": "1034.59",
"withoutTaxes": "796.63",
"icms-17.5-alc": "965.62",
"icms-19.5-alc": "989.61",
"icms-20.5-alc": "1002.06",
"icms-22.5-alc": "1027.92"
},
"pisCofinsList": "Positiva",
"substanceText": "LETROZOL",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "1111.41",
"icms-12": "1262.97",
"icms-17": "1339.06",
"icms-18": "1355.38",
"icms-19": "1372.11",
"icms-20": "1389.27",
"icms-21": "1406.86",
"icms-22": "1424.89",
"icms-23": "1443.40",
"icms-17.5": "1347.18",
"icms-19.5": "1380.64",
"icms-20.5": "1398.01",
"icms-22.5": "1434.08",
"icms-12-alc": "1251.48",
"icms-17-alc": "1326.87",
"icms-18-alc": "1343.06",
"icms-19-alc": "1359.63",
"icms-20-alc": "1376.62",
"icms-21-alc": "1394.05",
"icms-22-alc": "1411.93",
"icms-23-alc": "1430.26",
"withoutTaxes": "1101.30",
"icms-17.5-alc": "1334.91",
"icms-19.5-alc": "1368.08",
"icms-20.5-alc": "1385.29",
"icms-22.5-alc": "1421.04"
},
"invalidBarcodes": [],
"activeSubstances": [
"LETROZOL"
],
"therapeuticClass": "L2B3 - CITOSTÁTICOS INIBIDORES DA AROMATASE",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1023512820011",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L2B3",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:541819010100404"